7721 - 7730 of 8620 Results
Title
Year
- Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent manner2025OPENTitle: Alpha-synuclein knockout impairs melanoma development and alters DNA damage repair in the TG3 mouse model in a sex-dependent mannerJournal Name: Frontiers in OncologyPublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fonc.2025.1554059Best OA location URL: https://doi.org/10.3389/fonc.2025.1554059Citation Count: 0
-
OPENTitle: The Exon-Based Transcriptomic Analysis of Parkinson’s DiseaseJournal Name: BiomoleculesPublisher: MDPI AGVol: 15Issue #: 3Start Page: 440End Page: 440Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom15030440Best OA location URL: https://doi.org/10.3390/biom15030440Citation Count: 0
-
OPENTitle: Bidirectional relationship between olfaction and Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00838-4Best OA location URL: https://doi.org/10.1038/s41531-024-00838-4Citation Count: 0
- Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial2024OPENTitle: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trialJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 69Issue #:Start Page: 102474End Page: 102474Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdfCitation Count: 9
-
OPENTitle: Targeting short-chain fatty acids receptors signalling for neurological disorders treatmentJournal Name: Exploration of Neuroprotective TherapyPublisher: Open Exploration PublishingVol:Issue #:Start Page: 100End Page: 107Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.37349/ent.2024.00073Best OA location URL: https://www.explorationpub.com/uploads/Article/A100473/100473.pdfCitation Count: 2
- Single‐Molecule Counting Coupled to Rapid Amplification Enables Detection of α‐Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients2021OPENTitle: Single‐Molecule Counting Coupled to Rapid Amplification Enables Detection of α‐Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease PatientsJournal Name: Angewandte ChemiePublisher: WileyVol: 133Issue #: 21Start Page: 11981End Page: 11990Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ange.202014898Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ange.202014898Citation Count: 22
- Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal Tinnitus2015OPENTitle: Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal TinnitusJournal Name: BioMed Research InternationalPublisher: WileyVol: 2015Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2015/569052Best OA location URL: https://downloads.hindawi.com/journals/bmri/2015/569052.pdfCitation Count: 24
- A multi-layered stacked classifier developed for diagnosis of Parkinson’s disease and SWEDD patients using fusion of multimodal data2025RESTRICTEDTitle: A multi-layered stacked classifier developed for diagnosis of Parkinson’s disease and SWEDD patients using fusion of multimodal dataJournal Name: Biomedical Signal Processing and ControlPublisher: Elsevier BVVol: 108Issue #:Start Page: 107924End Page: 107924Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bspc.2025.107924Citation Count: 0
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease2011OPENTitle: Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 42Issue #: 3Start Page: 327End Page: 340Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2011.01.024Best OA location URL: https://lup.lub.lu.se/record/1831976Citation Count: 167
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 10